Search Results 661-670 of 12826 for hypercoagulable
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
Mayo Clinic Researchers Identify Gene that Pushes Normal Pancreas Cells to Change Shape, a Key Step to Cancer Development. Kevin Punsky. February 20, 2015.
This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...
Mayo Clinic researchers use new innovative technology to diagnose teen brothers with ultra-rare genetic disorder. When Emery Diffendorfer was a baby, ...
Mayo Clinic researcher harnesses uniqueness of space to advance medicine on Earth. Cancer, stroke, bone loss among diseases and conditions studied in ...
A medical charter: Commitments to limit physician burnout, promote well-being. Robert Nellis. March 29, 2018. Genomics Arrives at the Clinic featured image.
C difficile infection marketing campaign - landing - video · Share · Tweet ...
The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...
Mayo Clinic Comprehensive Cancer Center to highlight key studies at ASCO 2024. Kelley Luckstein. May 30, 2024. Mayo Clinic Minute: Benefits of an active ...
The study is an open-label, dose escalation clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.